Study title: A Dose-Escalation, Randomized Double-Blind Withdrawal Study of the Efficacy, Dose- Response, and Safety of Ramipril for the Treatment of Hypertension in Children and Adolescents
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Cardiovascular Diseases | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: RAMIPRIL | |||||
ATC code: C09AA05 | |||||
Document link: Ramipril-Study 3.pdf | |||||
Document date: 2011-09-06 | |||||
Study number: K726-01-4002 | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | Y | Y |